维普期刊资源整合服务平台（V6.5）

98篇 您的检索式：作者名="Paridaens R"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Proteases and metastasis: clinical relevance nowadays? 显示文摘	Decock J Paridaens R Cufer T	2005	Curr Opin Oncol2005，17，1：	1
2	PhaseⅢstudy comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women:The european organisation for research and treatment of cancer breast cancer cooperative group显示文摘	Paridaens R J Dirix L Y Beex L V	2008	J Clin Oncol2008，26，30：	1
3	Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer:a European Organization for Research and Treatment of Cancer Randomized Study with cross-over显示文摘	Biganzoli L Bruning P	2000	J Clin Oncol2000，18，4：	1
4	Mature results of a randomized phase Ⅱ multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer显示文摘	Paridaens R Dirix L Lohrisch C	2003	Ann Oncol2003，14，9：	1
5	Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors:final results of phase Ⅱ Swiss Group for Clinical Cancer Research Trial显示文摘	Perey L Paridaens R Hawle H	2007	Ann Oncol2007，18，1：	1
6	First mature analysis of the intergroup Exemestane study显示文摘	Coombes RC Paridaens R Jassem J	2006	J Clin Oncol2006，24，18：	1
7	Paclitaxel versus doxorubicin as firstline single agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer randomized study with crossover 显示文摘	Paridaens R	2000	J Clin Oncol2000，18，4：	1
8	An open label, multicenter study of outpatients capecitabine monotherapy in 631 patients with preteated advanced breast cancer显示文摘	Venturini M Paridaens R Rossner D	2007	Oncology2007，72，12：	1
9	A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood显示文摘	Aerts J Wynendaele W Paridaens R	2001	Annal Oncol2001，12，1：	1
10	First line hormonal treatment(HT) for metastatic breast cancer(MBC) with exemestane(E) or tamoxifen(T) in postmenopausal patients(pts)-A randomized phase Ⅲ trial of the EORTC Breast Group显示文摘	Paridaens R Therasse P Dirix L	2004	Proc Am Soc Clin Oncol2004，，：	1
11	An open-label,multicenter study of outpatient capecitabine monotherapy in 631 patients with pretreated advanced breast cancer显示文摘	Venturini M Paridaens R Rossner D	2007	Oncology2007，72，12：	1
12	Treatment of severe idio- pathic orbital inflammation with intravenous methylprednisolo- ne显示文摘	Bijlsma WR Paridaens D Kalmann R	2011	Br J Ophthalmol2011，95，8：	1
13	Syn- drome of inappropriate antidiuretic hormone associated with chemotherapy induced turnout lysis in small cell lung cancer: case report and literature review 显示文摘	Vanhees SL Paridaens R Vansteenkiste JF	2000	Ann Oncol2000，11，8：	1
14	First Mature Analysis of the Intergroup Exemestane Study 显示文摘	Coombes RC Paridaens R Jassem J	2006	Proceeding American Society of Clinical Oncology2006，24，：	1
15	A phase Ⅰ study of a new polyamine biosynthesis inhibitor,SAM486A,in cancer patients with solid tumours显示文摘	Paridaens R Uges DR Barbet N	2000	Br J Cancer2000，83，5：	1
16	Mature results of a randomized phase Ⅱ multicenter study of exemestane versus tamoxifeu as first-line hormone therapy for postmeuopausal women with metastatic breast cancer 显示文摘	PARIDAENS R DIRIX L LOHRISCH C	2003	Ann Oncol2003，14，9：	1
17	Comparison of proposed diagnoetic criteria with FACT-F and VAS for cancer-related fatigue:proposal for use as a screening tool显示文摘	Van Belle S Paridaens R Evers G	2005	Support Care Cancer2005，13，4：	1
18	Mature results of a randomized phase Ⅱ multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer显示文摘	Paridaens R Dirix L Lohrisch C	2003	Ann Oncol2003，14，9：	1
19	Multivariable re-gression analysis of febrile neutropenia occurrence in early breastcancer patients receiving chemotherapy assessing patient-related,chemotherapy-related and genetic risk factors显示文摘	Pfeil A M Vulsteke C Paridaens R	2014	BMC Cancer2014，14，：	1
20	Mature results of a randomized phase Ⅱ multicenter study of exemestane versus tamoxifen as first - line hormone therapy for postmenopausal women with metastatic breast cancer显示文摘	Paridaens R Dirix L Lohrisch	2003	Ann Oncol2003，14，9：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示